- JP-listed companies
- Kitazato Corporation
- Financials
- Pretax margin (%)
Kitazato Corporation (368A)
Market cap
¥48B
P/E ratio
12.1x
Kitasato Corporation develops and manufactures medical devices and reagents for reproductive medicine including IVF and egg freezing, serving hospitals and clinics in over 110 countries worldwide.
| Period End | Pretax margin (%) | YoY (%) |
|---|---|---|
| Mar 31, 2026 | 53.9 | -3.67% |
| Mar 31, 2025 | 56 | -5.88% |
| Mar 31, 2024 | 59.5 | +8.65% |
| Mar 31, 2023 | 54.7 | -0.41% |
| Mar 31, 2022 | 55 | +3.70% |
| Mar 31, 2021 | 53 | -7.69% |
| Mar 31, 2020 | 57.4 |